INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 412m ago
House PTR12m ago
SEC 13F11m ago
Robinhood Chain11m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELL
FFIVF5, INC.Nov 3 – Nov 5
8 insiders$8.37M
  • SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  • SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • Form 4 transactions

    73,606 records
    Side
    allbuysell
    Score
    any≥ 30≥ 50≥ 70
    Sort
    Newest disclosedNewest executedInsider ScoreValue
    Include
    grants & admin
    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    HS
    Harrington Paul SChief Supply Chain Officer
    SOLVSolventum Corp
    Option exercise
    M—
    10.5K sh
    Dec 1, 2025Dec 2, 2025
    Page 1704 of 1841
    ← PrevNext →
    traded Dec 1, 2025
    +1d
    SEC Form 4

    Evidence

    21
    PS
    Parks Kenneth ScottChief Financial Officer
    GEVGE Vernova Inc.
    Option exercise
    M—
    17.7K sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    21
    BW
    Bridges WendyEVP
    CMACOMERICA INC
    Option exercise
    M—
    757 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    21
    MS
    Ma StaceyDirector
    ELANElanco Animal Health Inc
    Grant or award
    A—
    10.3K sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    21
    CG
    Cota GermaineSVP, FINANCE & ACCOUNTING
    BILLBILL Holdings, Inc.
    Option exercise
    M—
    730 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    20
    LA
    Lezack AdamDirector
    BBNXBeta Bionics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$27K
    906 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    20
    PM
    Palasis MariaDirector
    BBNXBeta Bionics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$27K
    906 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    20
    LA
    Lezack AdamDirector
    BBNXBeta Bionics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$15K
    500 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    20
    PM
    Palasis MariaDirector
    BBNXBeta Bionics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$15K
    500 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    19
    BA
    Blum AlexanderSVP, Chief Operating Officer
    UUnity Software Inc.
    Open-market sale · 10b5-1 plan
    SELL$84K
    1,988 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    19
    OC
    Obiaya ChristianaDirector
    TTEKTETRA TECH INC
    Grant or award
    A—
    1,964 sh
    Nov 19, 2025Dec 2, 2025
    traded Nov 19, 2025
    +13dSEC Form 4

    Evidence

    19
    GP
    Gandhi PrashantDirector
    TTEKTETRA TECH INC
    Grant or award
    A—
    1,964 sh
    Nov 19, 2025Dec 2, 2025
    traded Nov 19, 2025
    +13dSEC Form 4

    Evidence

    19
    OJ
    Onyia JudeChief Scientific Officer
    NBIXNEUROCRINE BIOSCIENCES INC
    Tax withholding
    F$342K
    2,248 sh
    Nov 29, 2025Dec 2, 2025
    traded Nov 29, 2025
    +3dSEC Form 4

    Evidence

    18
    HL
    Hess Janice L.Director
    ESEESCO TECHNOLOGIES INC
    Option exercise
    M$1.15M
    5,623 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    18
    HL
    Hess Janice L.Director
    ESEESCO TECHNOLOGIES INC
    Option exercise
    M$1.15M
    5,623 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    17
    RJ
    Robins JasonDirector, See Remarks
    DKNGDraftKings Inc.
    Option exercise
    M—
    37.5K sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    17
    BJ
    Balance Austin JChief Product Officer
    GRNDGrindr Inc.
    Grant or award
    A—
    425.0K sh
    Nov 30, 2025Dec 2, 2025
    traded Nov 30, 2025
    +2dSEC Form 4

    Evidence

    17
    DM
    Dippold MichaelEVP and CFO
    DRSLeonardo DRS, Inc.
    Open-market sale · 10b5-1 plan
    SELL$179K
    5,294 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    17
    Huffman Steve LaddDirector, CEO & President, 10% Owner
    RDDTReddit, Inc.
    Open-market sale · 10b5-1 plan
    SELL$1.61M
    7,421 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    BK
    Bowman Mary KaySee Remarks
    BILLBILL Holdings, Inc.
    Option exercise
    M—
    7,336 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    KZ
    Katz ZacharyGC and Head of Global Affairs
    GRNDGrindr Inc.
    Grant or award
    A—
    270.0K sh
    Nov 30, 2025Dec 2, 2025
    traded Nov 30, 2025
    +2dSEC Form 4

    Evidence

    17
    LP
    Liberman PaulDirector, See Remarks
    DKNGDraftKings Inc.
    Option exercise
    M—
    22.1K sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    17
    PB
    Patadia Ankit B.EVP and Treasurer
    DOCHEALTHPEAK PROPERTIES, INC.
    Grant or award
    A$25K
    1,689 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    MG
    Mabry Adam GCIO
    DOCHEALTHPEAK PROPERTIES, INC.
    Grant or award
    A$12K
    844 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    OJ
    Onyia JudeChief Scientific Officer
    NBIXNEUROCRINE BIOSCIENCES INC
    Option exercise
    M—
    4,426 sh
    Nov 29, 2025Dec 2, 2025
    traded Nov 29, 2025
    +3dSEC Form 4

    Evidence

    17
    OC
    Obiaya ChristianaDirector
    TTEKTETRA TECH INC
    Option exercise
    M—
    1,718 sh
    Nov 30, 2025Dec 2, 2025
    traded Nov 30, 2025
    +2dSEC Form 4

    Evidence

    17
    MS
    McCaw SusanDirector
    LIONLionsgate Studios Corp.
    Grant or award
    A—
    20.1K sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    LA
    Lacerte Rene A.Director, CEO
    BILLBILL Holdings, Inc.
    Option exercise
    M—
    24.6K sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    DM
    Dorfman MarkEVP, GC and Secretary
    DRSLeonardo DRS, Inc.
    Open-market sale · 10b5-1 plan
    SELL$130K
    3,840 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    17
    BW
    Bridges WendyEVP
    CMACOMERICA INC
    Option exercise
    M—
    437 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    17
    BK
    Bowman Mary KaySee Remarks
    BILLBILL Holdings, Inc.
    Option exercise
    M—
    14.8K sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    CG
    Cota GermaineSVP, FINANCE & ACCOUNTING
    BILLBILL Holdings, Inc.
    Option exercise
    M—
    3,726 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    17
    LA
    Lacerte Rene A.Director, CEO
    BILLBILL Holdings, Inc.
    Option exercise
    M—
    5,358 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    16
    SM
    Stetz MattiasChief Operating Officer
    RSIRush Street Interactive, Inc.
    Open-market sale · 10b5-1 plan
    SELL$555K
    30.0K sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    16
    LJ
    Landes JonathanPresident, Subsea
    FTITechnipFMC plc
    Gift
    G—
    5,350 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    16
    PK
    Piskel KyleChief Financial Officer
    ADPTAdaptive Biotechnologies Corp
    Option exercise · 10b5-1 plan
    M$1.15M
    94.4K sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    16
    CG
    Cota GermaineSVP, FINANCE & ACCOUNTING
    BILLBILL Holdings, Inc.
    Tax withholding
    F$95K
    1,895 sh
    Nov 28, 2025Dec 2, 2025
    traded Nov 28, 2025
    +4dSEC Form 4

    Evidence

    16
    BW
    Bridges WendyEVP
    CMACOMERICA INC
    Option exercise
    M$122K
    1,925 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    16
    KJ
    Kramer Douglas JamesChief Legal Officer
    NETCloudflare, Inc.
    Open-market sale · 10b5-1 plan
    SELL$593
    3 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence

    16
    BA
    Brawley Charles A. IIIEVP, Gen Counsel, and Corp Sec
    CPBCAMPBELL'S Co
    Tax withholding
    F$103K
    3,373 sh
    Dec 1, 2025Dec 2, 2025
    traded Dec 1, 2025
    +1dSEC Form 4

    Evidence